Argenica Therapeutics Ltd (AGN) — Defensive Interval Ratio

Latest as of December 2025: 23 days

Argenica Therapeutics Ltd (AGN) has a Defensive Interval Ratio of 23 days as of December 2025. Defensive assets of AU$109.53K (cash AU$-, short-term investments AU$-, receivables AU$109.53K) cover 23 days of daily cash needs of AU$4.81K/day. Check AGN intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.

Defensive Interval Ratio

23 days
Days of operational coverage

Defensive Assets

AU$109.53K
Cash + ST Investments + Receivables

Daily Cash Need

AU$4.81K
Current Liabilities ÷ 365

Current Liabilities

AU$1.76 Million
AUD

Argenica Therapeutics Ltd Defensive Interval Ratio (2019–2024)

This chart shows how Argenica Therapeutics Ltd's Defensive Interval Ratio has evolved across 6 annual periods from 2019 to 2024. As of December 2025, the ratio stands at 23 days, meaning defensive assets of AU$109.53K can fund 23 days of operations without new revenue. Also explore Argenica Therapeutics Ltd (AGN) equity growth momentum to track the company's year-over-year net asset growth rate.

Annual Defensive Interval Ratio for Argenica Therapeutics Ltd (2019–2024)

The table below presents the year-by-year Defensive Interval Ratio for Argenica Therapeutics Ltd from 2019 to 2024, covering 6 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see market cap of Argenica Therapeutics Ltd.

Year DIR (days) Defensive Assets (AUD) Daily Cash Need Cash ST Investments Change (days)
2024 40 days AU$421.45K AU$10.42K/day AU$- AU$- ▼ -16 days
2023 56 days AU$372.08K AU$6.65K/day AU$- AU$- ▲ +17 days
2022 39 days AU$202.36K AU$5.14K/day AU$- AU$50.00K ▼ -24 days
2021 63 days AU$127.94K AU$2.02K/day AU$- AU$- ▼ -46 days
2020 109 days AU$127.27K AU$1.17K/day AU$- AU$- ▲ +74 days
2019 35 days AU$34.68K AU$984.28/day AU$- AU$-
DIR = (Cash + Short-term Investments + Net Receivables) / (Daily Cash Expenses)